GSK plc (LON:GSK)
1,979.50
-3.50 (-0.18%)
Jun 29, 2026, 4:49 PM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 79.02 billion as of June 29, 2026. Its market cap has increased by 31.81% in one year.
Market Cap
79.02B
Enterprise Value
94.25B
Revenue
32.78B
Ranking
n/a
PE Ratio
13.96
Stock Price
1,979.50
Market Cap Chart
Since April 12, 2000, GSK plc's market cap has increased from 67.16B to 79.02B, an increase of 17.65%. That is a compound annual growth rate of 0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 79.02B | 7.94% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 222.07B |
| Haleon | 30.71B |
| Smith & Nephew | 9.66B |
| Convatec Group | 4.14B |
| Hikma Pharmaceuticals | 3.26B |
| Genus | 1.44B |
| HUTCHMED (China) | 1.38B |
| Oxford Nanopore Technologies | 1.21B |